Targeting ATP2B1 impairs PI3K/Akt/Fox-O3 signaling and reduces SARS-COV-2 replication in vivo.
Pasqualino De Antonellis, Veronica Ferrucci, Francesca Bibbò, Fathem Asadzadeh, Francesca Gorini, Angelo Sabato Boccia, Carmen Sorice, Roberto Siciliano, Roberta Russo, Immacolata Andolfo, Vito Alessandro Lasorsa, Sueva Cantalupo, Giovanni Paolella, Giovanna Fusco, Maurizio Viscardi, , Massimo Zollo
This study shows that inhibiting ATP2B1 with compound PI-7 reduces SARS-CoV-2 replication by lowering intracellular calcium levels and disrupting the PI3K/Akt/FoxO3 signaling pathway.
medRxiv · Sep 2, 2022 · PreprintGenetic & Genomic Medicine